Rationale Problematic drug use is associated with difficulty in exerting self-control over behaviors, and this difficulty may be a consequence of atypical morphometric characteristics that are exhibited by drug-experienced individuals. The extent to which these structural abnormalities result from drug use or reflect neurobiological risk factors that predate drug use, however, is unknown. Objectives The purpose of this study is to determine how methamphetamine affects corticostriatal structure and how drug-induced changes relate to alterations in inhibitory control. Methods Structural magnetic resonance images and positron emission tomography (PET) scans, assessing dopamine D 2 -like receptor and transporter availability, were acquired in monkeys trained to acquire, retain, and reverse three-choice visual discrimination problems before and after exposure to an escalating dose regimen of methamphetamine (or saline, as a control). Voxel-based morphometry was used to compare changes in corticostriatal gray matter between methamphetamine-and saline-exposed monkeys. The change in gray matter before and after the dosing regimen was compared to the change in the behavioral performance and in dopaminergic markers measured with PET.
Introduction
Substance-use disorders are associated with cognitive abnormalities that are thought to reflect, in part, neurobiological dysfunction caused by long-term exposure to drugs of abuse. This view is supported by observations that exposure of animals to drugs can produce cognitive and neural alterations that resemble those that are exhibited by substance-dependent humans (Jentsch et al. 2002; Nader et al. 2006; Porter et al. 2011 Porter et al. , 2012 Groman et al. 2012) . The coupling of neural changes following drug exposure with alterations in cognition (Groman et al. 2012 ) underscores the functional impact of such changes on behavior.
Of the drug-induced effects on cognition, impairment in the ability to exert inhibitory control over behavior is the topic of much research (Izquierdo and Jentsch 2012) . Difficulty with stopping or withholding behaviors has been proposed to be a central feature of substance dependence (Jentsch and Taylor 1999) , and emerging evidence indicates that the relationship between inhibitory control and substance dependence is bidirectional. Specifically, pre-existing differences in inhibitory control predict future drug-taking behaviors (Dalley et al. 2007; Diergaarde et al. 2008; Perry et al. 2008; Anker et al. 2009) , and chronic exposure to drugs of abuse can cause inhibitory control impairments to emerge (Jentsch et al. 2002; Schoenbaum et al. 2004; Schoenbaum and Setlow 2005) , indicating that inhibitory control deficits are both a cause and consequence of substance dependence (Groman and Jentsch 2013) . Further, variability in the degree of inhibitory-control impairments exhibited by substancedependent individuals has been reported to predict measures of sobriety (Aharonovich et al. 2006; Turner et al. 2009 ), suggesting that improving inhibitory control, through behavioral or pharmacological mechanisms, may serve as effective intervention and treatments for substance dependence . One type of inhibitory control involves the ability to modify behavior adaptively when contingencies change, and lesions to the prefrontal cortex impair this ability in humans and animals (Dias et al. 1996; Fellows and Farah 2003; Rygula et al. 2010) , suggesting that the prefrontal cortex is critical for the maintenance of flexible, goal-directed behaviors (Clarke et al. 2004) . Indeed, individual differences in gray-matter volume within the prefrontal cortex are related to performance on tasks of inhibitory control in healthy humans and monkeys (Haldane et al. 2008; Tabibnia et al. 2011; Sridharan et al. 2012) . The dorsal striatum also plays a critical role in inhibitory control processes (Bellebaum et al. 2008; Castane et al. 2010; Clarke et al. 2011) , suggesting that inhibitory control relies on an integrated network of nuclei within the corticostriatal system. Inhibitory control deficits exhibited by stimulant-dependent individuals may reflect dysfunction in corticostriatal circuitry (Baicy and London 2007) . Consistent with this hypothesis, on average, samples of methamphetamine-dependent research participants have smaller gray-matter volumes in the prefrontal cortex (Thompson et al. 2004; Morales et al. 2012 ) and larger gray-matter volumes in the striatum (Chang et al. 2005; Jernigan et al. 2005 ), relative to methamphetamine-naive controls. While recent evidence suggests that some differences in gray-matter volume between stimulant abusers and healthy individuals are also detected in unaffected siblings of stimulant abusers (Ersche et al. 2012) , no studies to date have examined whether exposure to methamphetamine causally alters gray matter in corticostriatal circuitry and whether these changes have a functional impact on measures of inhibitory control.
In order to address these questions, the current study was performed using voxel-based morphometry to measure gray matter structure in monkeys trained to acquire, retain, and reverse visual discrimination problems before and after a 31-day escalating dose regimen of methamphetamine (or saline) administration. Based on the available evidence, we hypothesized that exposure to methamphetamine would decrease gray matter within the prefrontal cortex, but increase gray matter within the striatum. Further, we expected that the changes in gray matter would be correlated with changes in reversal learning performance and dopaminergic markers in the same animals reported previously (Groman et al. 2012 ).
Methods
Subjects Fourteen adult, male vervet monkeys (Chlorocebus aethiops sabaeus from the UCLA Vervet Research Colony), between the ages of 5 and 9 years of age, were included in the current study. The monkeys were housed in a climatecontrolled vivarium, where they had unlimited access to water and received twice-daily portions of standard monkey chow in amounts that exceeded their nutritional needs (Teklad, Harlan Laboratories). Monkeys received half of their daily portion of chow after behavioral testing (∼1100 h) and the other half in the afternoon (∼1500 h). The total amount of chow was never reduced during the experiment to increase motivation for task performance. All monkeys were maintained in accordance with the Guide for the Care Drugs and dosing regimen Methamphetamine hydrochloride was purchased from Sigma-Aldrich (St. Louis, MO). Doses of methamphetamine were prepared fresh daily in 0.9 % saline and were sterile-filtered prior to administration. Injections were administered intramuscularly at a volume of 0.1 ml/kg. The dosing regimen was designed to model the escalation in both frequency of intake and cumulative daily dose reported by human users of methamphetamine (Han et al. 2011) . Methamphetamine was initially administered once per day at 0.1 mg/kg, but the dose and frequency escalated across the 31-day period, with the final dose of 1.0 mg/kg being administered four times per day. Details of the dosing regimen are provided in Table 1 . The initial daily dose was administered at 0830 h. During week 2, a second daily dose was administered at 1630 h. During weeks 3 through 5, the second daily dose was administered at 1330 h, and a third daily dose given at 1630 h. For the last 2 weeks of treatment, the second daily dose was administered at 1100 h, the third at 1330 h, and a fourth at 1600 h.
Discrimination acquisition, retention, and reversal learning As previously described in detail Groman et al. 2012) , subjects were trained to acquire, retain, and reverse visual discrimination problems in a modified Wisconsin General Testing Apparatus. On each trial, monkeys were allowed to open a single box. A trial ended when the subject made a correct response to rewarded stimulus (rewarded with a small piece of fruit), an incorrect response, or an omission occurred (no response for 2 min), and a 20-s inter-trial interval followed. The spatial position of the different visual stimuli was varied pseudorandomly across trials.
Each discrimination problem consisted of three phases: acquisition, retention, and reversal. In the acquisition phase, subjects were required to learn which one of the three visual stimuli was associated with reward solely through feedback provided by the task. Once the performance criterion was met (seven correct choices within ten consecutive trials), the session was terminated, and the monkey returned to the home cage. If the monkey did not reach the performance criterion within 80 trials, the session ended and the same discrimination problem presented the following day(s) until the performance criterion was met. One day after reaching criterion, subjects were assessed in the retention phase, where the stimulus-reward contingencies remained unchanged. Immediately after reaching the performance criterion (four correct responses within five consecutive trials), unsignaled to the monkey, the reversal phase began. In the reversal phase, the stimulus-reward contingencies changed such that the previously rewarded stimulus was no longer rewarded and one of the two previously non-rewarded stimuli was rewarded. The reversal phase continued until the performance criterion was met (seven correct choices within ten consecutive trials) or until 80 trials had been completed, whichever occurred first. The number of trials required to reach criterion in the reversal phase was the primary dependent measure.
Subjects were trained on several novel discrimination problems before and after the 31-day dosing regimen, each using novel stimuli. Drug effects on behavioral performance were determined by comparing data at three time points: (1) behavioral performance of subjects in the discrimination problem completed immediately prior to beginning the dosing regimen referred to as the "baseline assessment"; (2) performance during 3 weeks within the course of the treatment regimen (referred to as the "3 week assessment"; to limit the anorectic effects of methamphetamine, this test occurred after at least 36 h had elapsed since the last methamphetamine or saline administration); and (3) performance at 5 days after the last drug administration (referred to as the "5-day post-exposure assessment"). The baseline data for 12 of the 14 monkeys used in the current study have been reported , as were the behavioral data before and after the dosing regimen (Groman et al. 2012) .
After completion of the dose regimen, two additional behavioral assessments were conducted, but the performance criterion was increased (nine correct choices in 10 completed trials for the acquisition, retention, and reversal phases) to augment the cognitive demands of the task. Specifically, the additional acquisition and retention training was expected to increase the likelihood of perseverative responding; these two "high-difficulty" sessions were conducted at 8 d and 2 weeks after cessation of drug administration (referred to as the "8 d post-exposure assessment" and the "2 week postexposure assessment," respectively).
For the purposes of the current study, changes in gray matter were compared to the change in reversal learning performance between the baseline assessment and the 5-day post-exposure assessment, as these assessments used the same performance criterion. The number of trials required to reach criterion in reversal phase of the baseline assessment was subtracted from the number of trials required to reach criterion in the reversal phase of the 5-day postexposure assessment to calculate a behavioral difference score.
MRI scanning procedures Each subject underwent structural magnetic resonance (MR) imaging twice: 2-3 weeks prior to initiating the dosing regimen (referred to as the "Baseline" scan) and 3.5 weeks after completion of the dosing regimen (referred to as the "Post-Dosing Regimen" scan). On scan days, monkeys received an intramuscular injection of ketamine hydrochloride (10 mg/kg) and atropine sulfate (0.01-mg/kg). Once the monkey was sedated, an endotracheal tube was placed to provide inhalation of 2-3 % isoflurane gas (in 100 % O 2 ) for the duration of the scan (approximately 1 h). Nine T1-weighted volumes with three-dimensional, magnetization-prepared, rapid-acquisition, gradient-echo (MPRAGE) images were acquired (TR = 1,900 ms TE= 4.38 ms, FOV=96 mm, flip angle 15°, voxel size 0.5 mm, 248 slices, slice thickness 0.5 mm) using a 1.5-T Siemens Sonata scanner and an eight-channel, high-resolution, kneearray coil (Invivo Corporation).
PET scanning procedures Three PET scans were collected, as previously described (Groman et al. 2012 ): (1) ∼2 weeks prior to initiating the dosing regimen (referred to as the "baseline scan"), (2) ∼2 weeks after the last drug administration to examine the immediate effects of methamphetamine (referred to as "2-week post-exposure scan"), and (3) ∼7 weeks after the last drug administration to examine the stability of neural changes (referred to as the "7-week post-exposure scan"). PET scanning was completed using [ 11 C]WIN-35428 and [ 18 F]fallypride as radioligands for assessing DAT and D 2 -like receptor availability, respectively. For the current study, D 2 -like and DAT availability measurements collected at the 2-week post-exposure scan were used, as these measurements were closest in time to when the second MR image was collected. Difference scores were calculated by subtracting the availability measurements obtained at the 2-week post-exposure scan from the baseline scan.
Data processing
MR image pre-processing The nine MPRAGE sequences were motion-corrected using Statistical Parametric Mapping 5 (SPM; Institute of Neurology, University College London, London, England) and averaged. The images were aligned such that the anterior and posterior commissures were in the same plane, field-bias corrected, and manually skull-stripped.
Developing tissue class priors for MR image segmentation in vervet monkey Tissue class priors, which indicate the likelihood of finding a given tissue class at a given location, were created by manually defining and smoothing (3 mm FWHM Gaussian kernel) gray matter, white matter, and cerebrospinal fluid on a vervet monkey template. Ten vervet monkey scans, collected for a different study (Fears et al. 2009 ), were segmented using SPM5, with the following changes to the default parameters: human tissue classification priors were replaced with the maps of tissue classification created from the vervet template, no affine regularization was conducted, and the sampling distance was changed from 3 to 1 mm. The resulting segmentations were averaged to create probability maps of gray matter, white matter, and CSF.
Processing of MR images Baseline and post-dosing regimen MR images for each subject were moved into a position located halfway between the two images, using Advanced Normalization Tools (Avants et al. 2011) , and the baseline and post-dosing scans were averaged to create a mean image. The mean, baseline, and post-dosing regimen MR images were then segmented into gray matter, white matter, and CSF, using SPM5. The following segmentation parameters were changed from the default settings: human priors were replaced with the vervet monkey priors, no affine regularization was conducted, and the sampling distance was changed from 3 to 1 mm. Diffeomorphic Anatomical Registration using Exponential Lie Algebra was then used to register each subject's mean gray-matter image to template space. Baseline and post-dosing regimen gray-matter images were moved to template space using the nonlinear deformation parameters generated by the registration of each subject's mean gray-matter image to template space (summarized in Fig. 1 ). In the resulting gray-matter images, intensity at each voxel represents the proportion of gray matter with a region.
Reconstruction and processing of PET images PET images were reconstructed as previously described (Groman et al. 2012) . Activity was extracted from each subject's PET image using previously defined regions of interest and imported into the PMOD kinetic analysis program (PMOD v3.15). Time-activity curves were fit using the Multilinear Reference Tissue Model (Ichise et al. 2003) , using the activity from the cerebellum as the reference. K2′, the rate constant of tracer transfer from the reference region (cerebellum) to plasma, was extracted from the high-activity areas of the caudate nucleus and putamen and averaged together. The time-activity curves were then refit with MRTM2 using the average fixed k2′ value applied to all brain regions.
Statistical analysis
In order to determine whether exposure to methamphetamine had a different effect on gray matter than saline, difference images were created by subtracting the intensity of graymatter images obtained from the post-dosing regimen scan from that of the baseline scan. These difference images were then smoothed using a 5-mm FWHM Gaussian function (McLaren et al. 2010) . A general linear model (GLM) was created to statistically test the following: (1) whether the difference in gray matter within saline-exposed monkeys was greater than that in methamphetamine-exposed monkeys, (2) whether the difference in gray matter within methamphetamine-exposed monkeys was greater than that in saline-exposed monkeys, (3) whether the difference in gray matter between the baseline and post-dosing regimen was statistically significant in salineexposed monkeys, and (4) whether the difference in gray matter between baseline and post-dosing regimen was statistically significant in methamphetamine-exposed monkeys. The GLM was then implemented in FSL RANDOMISE v2.1 tool (Permutation-based nonparametric inference, Oxford University, Oxford UK) with a variance smoothing of 5 mm (FWHM Gaussian). Threshold-free cluster enhancement (TFCE; Smith and Nichols 2009) was used to detect significant clusters of change; this method provides the ability to perform cluster-based inference without the need to specify an arbitrary cluster-forming threshold, as is necessary when using Gaussian random field theory. For each analysis, 10,000 randomization runs were performed. Statistical maps were thresholded at p<0.05 and corrected for the search volume contained in the following regions of interest, selected based on evidence that gray-matter volume or density in methamphetamine-dependent individuals is altered in these regions (Thompson et al. 2004; Chang et al. 2005; Jernigan et al. 2005; Morales et al. 2012) : orbitofrontal cortex, ventral medial prefrontal cortex, cingulate cortex, insula, caudate, putamen, and ventral striatum.
To determine the dependency between changes in gray matter and changes in the number of trials required to reach criterion in the reversal phase in the methamphetamineexposed monkeys, the difference in the number of trials required to reach criterion in the reversal phase before and after the dosing regimen was regressed against the difference in gray matter using RANDOMISE with variance smoothing of 5 mm (FWHM) and, based on the results of the analysis described above, confined to the search volume of the bilateral putamen. Ten thousand randomization runs were performed, and TFCE was used to detected significant correlation clusters. Statistical maps were thresholded at p<0.05 and corrected for the entire search volume of the putamen.
The relationship between changes in gray matter and changes in D 2 -like receptor and DAT availability were examined by regressing the difference in the availability of these dopaminergic markers within the right putamen (2-week post-exposure scan-baseline) against the difference in gray matter using RANDOMISE with variance smoothing of 5 mm (FWHM) and, based on the results of analysis described above, confined to the search volume of the bilateral putamen. Ten thousand randomization runs were performed, and TFCE used to detected significant correlation clusters. Statistical maps were thresholded at p<0.05 and corrected for the entire search volume of the putamen. Effect size maps (Cohen's d) were created by taking the square root of the mean difference in intensity of the gray-matter images in methamphetamine-exposed monkeys to that of saline-exposed monkeys divided by the pooled standard deviation in the difference values. Correlation coefficients, obtained from Pearson's product-moment correlations, were compared between data from methamphetamine-and salineexposed monkeys using Fisher's r-to-z transform.
Results
Brain morphometry Voxel-wise analysis examining whether methamphetamine produced changes in gray matter that differed from changes in the control condition detected a significant cluster, located within the caudal portion of the right putamen (Fig. 2a) . A similar cluster was observed in the left putamen; however, it did not survive corrections for multiple comparisons. The simple-effects contrasts examining the difference in gray matter in saline or methamphetamine monkeys indicated that the interaction was due to a significant change in gray matter within the right putamen of methamphetamineexposed monkeys (Fig. 2b) , as no significant clusters were detected in the saline-exposed monkeys. Values extracted from the significant interaction cluster revealed that, on average, gray matter increased in methamphetamine-exposed monkeys by Fig. 1 A diagram of the processing stream used in the current study for the structural MR images 5.2 % (±1.2 % SEM), while gray matter decreased in salineexposed monkeys by 0.8 % (±1.5 %; SEM). The overlap between the significant interaction cluster and simple-effect cluster is presented in Fig. 2c , and the raw gray-matter intensity values are plotted in Fig. 2d . Effect size (Cohen's d) maps, comparing changes in gray matter between methamphetamineand saline-exposed monkeys within the regions of interest (Fig. 3) , allow for qualitative comparison of differences between groups that did not reach the prescribed statistical threshold.
Acquisition, retention, and reversal performance As previously described (Groman et al. 2012 ), analysis of behavioral performance of monkeys before, during, and after the dosing regimen revealed no significant differences between the groups for the number of trials required to reach criterion in the acquisition phase or retention phase. However, the number of trials required to reach criterion in the reversal phase significantly diverged between the groups across the behavioral assessments (group by discrimination session, p<0.001). Post hoc analyses confirmed that this was due to a significant increase in the number of trials required to reach criterion in the methamphetamineexposed monkeys between baseline and the 3-week assessment (p<0.001); however, no other pairwise comparisons were significant (all ps>0.81).
Correlation of changes in inhibitory control with changes in gray matter morphometry To determine whether the change in putamen gray matter detected in the methamphetamineexposed monkeys was behaviorally relevant, we tested for a correlation between the change in the number of trials required to reach criterion in the reversal phase after methamphetamine exposure and the difference in gray matter within the putamen. The voxel-wise analysis of this regression revealed a significant cluster located within the caudal portion of the right putamen (Fig. 4a) , overlapping with the time-bydosing regimen cluster detected above (Fig. 4b) . The change in gray matter was positively correlated with the change in reversal-learning performance, such that the increased gray matter was associated with a greater number of trials needed to reach criterion in the reversal phase in methamphetamineexposed monkeys (Fig. 4d) . The relationship was not statistically significant in saline-exposed monkeys (Fig. 4c) .
Covariation of dopaminergic markers with gray-matter morphometry Previously, we demonstrated that exposure to an escalating dose of methamphetamine significantly reduced D 2 -like receptor and DAT within the striatum of the animals tested here (Groman et al. 2012) . To determine whether changes in markers of the dopamine system were correlated with changes in gray matter, the change in these dopaminergic markers within the right putamen before and after the dosing regimen was regressed against changes in gray matter within the putamen. The voxel-wise analysis revealed a significant cluster located within the caudal portion of the right putamen for the change in D 2 -like receptor availability (Fig. 5a) as well as the change in DAT availability (Fig. 5b) . The correlation coefficients did not differ between saline-or methamphetamine-exposed monkeys for Fig. 2 Statistical maps (p values) for the voxel-wise analysis of changes in gray matter with exposure to an escalating dose regimen of saline (SAL; N=7) or methamphetamine (MA; N= 7).The significant time-by-drug exposure interaction detected in the right putamen is presented in (a), and the simple effects contrast presented in (b). The overlap between the interaction cluster and the simple effect cluster is presented in (c). For illustrative purposes, the intensity of the gray-matter images at the baseline and postdosing scan in monkeys exposed to saline (closed circles) or methamphetamine (open circles) is presented in (d) Fig. 3 Effect size maps (Cohen's d) comparing the change in gray matter between methamphetamine-and salineexposed monkeys. Cooler values are indicative of gray matter loss (darker to lighter blue represents lower to greater negative effects) in the methamphetamine-exposed monkeys compared to the saline-exposed monkeys, while hotter values are indicative of increases in gray matter (darker to lighter red represents lower to greater positive effects) in methamphetamine-exposed monkeys compared to salineexposed monkeys Fig. 4 Statistical maps (p values) for the voxel-wise regression of changes in gray matter within the putamen on change in reversal learning performance. The change in the number of trials required to reach criterion in the reversal phase was positively related to the change in gray matter, which is presented (a). This cluster overlapped with the time-by-dosing regimen interaction on gray matter as presented in (b). The relationship was only detected in the methamphetamine-exposed monkeys (d), as the change in gray matter did not significantly correlate with the change in reversal learning performance within the salineexposed monkeys (c). Scatter plots are for illustrative purposes only D 2 -like receptor availability (Fig. 5c ) or for DAT availability (Fig. 5d) .
Discussion
These data provide the first evidence that exposure to a prolonged, escalating dosing regimen of methamphetamine designed to mimic aspects of human use patterns produces long-lasting alterations in the structural integrity of the striatum that can be measured in vivo with sMRI, and suggest that the structural abnormalities previously detected in methamphetamine-dependent humans are, at least in part, a consequence of drug use. The degree of change in gray matter within the right putamen correlated with change in reversal-learning performance, providing evidence that the structural alterations have a functional impact on inhibitory control, a process that may be central to addiction. Finally, changes in dopaminergic markers within the putamen were correlated with the change in gray matter, suggesting that the methamphetamine-induced biochemical alterations may be related to the structural change.
Escalation of methamphetamine administration results in increased gray matter in right putamen
Previous studies have indicated that gray-matter volume within the putamen is greater in methamphetamine-dependent humans compared to control subjects (Chang et al. 2005; Jernigan et al. 2005; Churchwell et al. 2012) . Although these morphometric differences have long been presumed to be an effect of chronic drug use (Chang et al. 2007) , recent evidence has suggested that greater putamen gray-matter volume may be present prior to drug use (Ersche et al. 2012) , with these structural differences possibly influencing the development of substance abuse and/or dependence. The results of the current study support the former hypothesis, demonstrating that gray matter in the putamen increased following exposure to methamphetamine in a manner similar to the differences detected in humanmethamphetamine users. This is not to say that gray-matter volume differences in the putamen are not both a cause and consequence of stimulant dependence.
Unlike previous studies that have detected gray-matter abnormalities in the prefrontal cortex of methamphetaminedependent humans (Thompson et al. 2004; Morales et al. 2012) , prefrontal gray matter was not significantly different in monkeys exposed to methamphetamine than in monkeys exposed to saline. The discrepancy between the human studies and the current study could reflect a variety of factors. One possibility is that changes in prefrontal gray matter produced by 31 days of methamphetamine exposure may be on a smaller scale than that those in putamen, requiring a larger sample size than that used here to detect the change (as evidenced by the effect size maps presented in Fig. 3 ). Changes in prefrontal cortical structure may occur at a slower rate than those in the putamen, emerging only after extensive periods of drug use (several years). Supporting this hypothesis is evidence that prefrontal graymatter volume/density in heroin-and cannabis-dependent individuals is negatively correlated with duration of drug use (Yuan et al. 2009; Stone et al. 2012) . It is also possible that some of the abnormalities in prefrontal cortex detected in methamphetamine-dependent individuals are attributable to factors other than methamphetamine exposure. For example, a large proportion of methamphetamine-dependent individuals smoke tobacco cigarettes, and some abnormalities in prefrontal gray-matter volume observed in methamphetaminedependent individuals may be attributable to cigarette smoking (Morales et al. 2012) . Finally, given that prefrontal gray-matter volume is smaller in drug-naive individuals who are at greater than normal risk for developing alcoholism (Benegal et al. 2007) , it is also possible that the differences in prefrontal gray-matter volume observed in methamphetamine abusers predate drug use may reflect and increased vulnerability to developing methamphetamine dependence.
Potential mechanisms for the methamphetamine-induced increase in putamen gray matter Although several studies have indicated that gray matter in the striatum is altered in methamphetamine-dependent individuals (Chang et al. 2005; Jernigan et al. 2005; Churchwell et al. 2012; Ersche et al. 2012; Morales et al. 2012) , the mechanism by which these alterations occur is unknown. Greater gray-matter volume/density in the putamen may be indicative of increased neuronal density (Tulloch et al. 2011) , alterations in the morphology of the existing neurons (e.g., increased spine density) (Jedynak et al. 2007 ), or, as had been previously proposed, an inflammatory response to methamphetamine exposure (Kousik et al. 2012) . In animals, administration of methamphetamine increases activation of astroglia, microglia, and other markers of inflammation that have been proposed to mediate the neurotoxic effects of methamphetamine on the dopamine system (Asanuma et al. 2003) , and administration of drugs that prevent microglial activation prevents the methamphetamine-induced dopamine alterations (Thomas and Kuhn 2005) . Measurements of microglial activation in methamphetamine-dependent people suggest that reactive gliosis can persist for at least 2 years following the initiation of abstinence from methamphetamine (Sekine et al. 2008) . The changes in gray matter detected in the current study were still present 3 weeks after the final dose of methamphetamine was administered and were correlated with changes in measures of D 2 -like and DAT availability, suggesting that changes in putamen morphometry are longlasting and co-occur with changes in the putamen dopamine system, possibly arising from inflammation.
The increase in gray matter observed here was greater in the right putamen, with a similar, nonsignificant trend observed in the left putamen; however, nonsignificant decreases in gray matter were observed in the caudate nucleus (see effect size map, Fig. 3 ). An emerging literature suggests that exposure to methamphetamine has differential effects in striatal subregions. Repeated exposure to methamphetamine increases spine density on medium spiny neurons in the dorsolateral striatum, but decreases spine density in the immediately adjacent dorsomedial striatum (Jedynak et al. 2007 ), the rodent striatal subregions believed to be orthologous to the primate putamen and caudate, respectively. Methamphetamine exposure also results in alterations in the vasculature of the dorsal but not ventral striatum (Kousik et al. 2011) , possibly producing a spatially restricted hypoxic environment and inflammatory response. Data from human studies suggest that stimulantdependent individuals have smaller gray-matter volume in the caudate than stimulant-naive individuals (Morales et al. 2012; Moreno-Lopez et al. 2012) , in contrast to findings indicating greater volume in the putamen. Taken together, this evidence suggests that methamphetamine exposure differentially alters regions within the striatum, which may differentially alter the behavioral effects of methamphetamine by simultaneously altering the neural circuits that underlie goal-directed (dorsomedial striatum) and habitual (dorsolateral striatum) behaviors. However, additional studies with larger samples are needed.
Correlation of methamphetamine-induced changes in gray matter with changes in inhibitory control Emerging evidence indicates that the ability to exert inhibitory control over behaviors relies on several regions within the corticostriatal circuit (Castane et al. 2010 ). Lesions to the orbitofrontal cortex and dorsal striatum produce similar impairments in reversal-learning performance, indicating that the ability to modify behaviors adaptively, upon a change in contingencies, depends upon the coordinated activity of nuclei within the corticostriatal circuit. In the current study, the methamphetamine-induced increases in gray matter in the putamen were positively correlated with the change in reversal-learning performance, demonstrating that the morphometric changes had a detrimental impact on a behavioral process that is altered in human methamphetamine users (Ghahremani et al. 2011) .
Conversely, striatal gray-matter volume in human methamphetamine-dependent subjects is negatively correlated with measures of cognitive function (Chang et al. 2005; Jan et al. 2012) . The discrepancy between the current findings and this observation may reflect temporal differences in the effects of methamphetamine. For example, during the initial phases of drug use, the effect of methamphetamine on the putamen may be the greatest, producing the largest inflammatory response and alterations to the dopamine system. Consistent with this hypothesis, in adolescent methamphetamine abusers, the number of lifetime doses of methamphetamine is positively correlated with gray-matter volume in the putamen (Churchwell et al. 2012) . In adults who abuse methamphetamine, however, years of methamphetamine abuse are negatively correlated with gray-matter volume in the putamen (Chang et al. 2005) , suggesting that as use of the drug continues, tolerance develops and compensatory mechanisms are recruited as an adaption to the persistent presence of methamphetamine, which may then impact cognitive processes in a different way than when methamphetamine use initially began.
These data highlight the neural and behavioral variability that exists between individuals in response to methamphetamine. Despite receiving identical doses and cumulative amounts of methamphetamine, the impact of methamphetamine on gray matter was minimal in some individuals (<2 %) and great in others (∼11 %) suggesting that unidentified biological and/or genetic factors may mediate the neural response of individuals to methamphetamine. The current study found that changes in gray matter within the methamphetamine-exposed monkeys correlated with the changes in reversal learning performance, suggesting that individual differences in methamphetamineinduced gray matter changes have a functional and meaningful impact on behaviors that may contribute to the pathophysiology of methamphetamine dependence.
Future directions for understanding the pathophysiology of methamphetamine dependence These data support the notion that greater putamen graymatter volume in methamphetamine-dependent than in methamphetamine-naïve individuals is, in part, a consequence of drug use; however, the etiology and reversibility of these methamphetamine-induced changes remain unknown. Future studies in animals, combining sMRI assessments of brain structure with histological measurements, have the potential to link gross anatomical changes to changes at the cellular level. In humans, multimodal neuroimaging, incorporating measures of microglial activation (Sekine et al. 2008) , may be used to test the hypothesis that changes in gray matter reflect inflammation. Since the current study found that exposure to methamphetamine produced changes in morphometry that functionally impacted behaviors previously shown to predict aspects of sobriety in substance-dependent individuals (Aharonovich et al. 2006; Turner et al. 2009 ), determining the etiology of these morphometric changes may identify novel targets for the treatment of methamphetamine dependence.
